InsidersTradesSigma
Total declarations
Company
▲ Purchases (15 ops.)
▼ Sales (0 ops.)
Insider track record
CEODisclosed buys
15
Disclosed sells
0
T+90 hit rate
0%
T+90 mean return
-45.1%
Across 12 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Fraser Craig, Chairman & CEO. Officer active across 1 company, notably Windtree Therapeutics INC. Cumulatively, 18 reports have been logged. Split: 15 buys · 0 sell. Total volume traded: €37k. Activity tracked since 19 October 2021. The latest transaction was disclosed on 8 October 2024 (Acquisition). Regulator: SEC (Form 4). The full history is openly available.
Companies and markets linked to Fraser Craig
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations18 total
5,431 shares@ US$0.90999.1% of flowCommon StockSEC:0001437749-24-030918:0
Canonical exit: 6 Jan 2025 (T+90)
2,500 shares@ US$1.01995.4% of flowCommon StockSEC:0001437749-23-026969:0
Canonical exit: 26 Dec 2023 (T+90)
2,500 shares@ US$0.904.7% of flowCommon StockSEC:0001437749-23-026828:0
Canonical exit: 25 Dec 2023 (T+90)
45,867 shares0Common StockSEC:0001437749-23-024710:0
1,497 shares@ US$1.774.8% of flowCommon StockSEC:0001437749-23-011245:0
Canonical exit: 25 Jul 2023 (T+90)
1,315 shares@ US$1.894.6% of flowCommon StockSEC:0001437749-23-011064:0
Canonical exit: 24 Jul 2023 (T+90)
334 shares0Common StockSEC:0001437749-23-005268:0
2,500 shares@ US$0.37991.9% of flowCommon StockSEC:0001437749-22-017890:0
Canonical exit: 25 Oct 2022 (T+90)
2,500 shares@ US$0.3741.9% of flowCommon StockSEC:0001437749-22-017791:0
Canonical exit: 24 Oct 2022 (T+90)
4,500 shares@ US$0.42793.7% of flowCommon StockSEC:0001437749-22-016607:0
Canonical exit: 28 Sept 2022 (T+90)
7,000 shares@ US$0.415448.24% mcap8.7% of flowCommon StockSEC:0001437749-22-016227:0
Canonical exit: 27 Sept 2022 (T+90)
2,000 shares@ US$0.97994.8% of flowCommon StockSEC:0001437749-22-006612:0
Canonical exit: 14 Jun 2022 (T+90)
3,000 shares@ US$0.98017.2% of flowCommon StockSEC:0001437749-22-006313:0
Canonical exit: 13 Jun 2022 (T+90)
166,900 shares0Common StockSEC:0001437749-22-005417:0
930 shares@ US$1.603.5% of flowCommon StockSEC:0001437749-21-027198:0
Canonical exit: 17 Feb 2022 (T+90)
930 shares@ US$1.613.6% of flowCommon StockSEC:0001437749-21-027085:0
Canonical exit: 16 Feb 2022 (T+90)
3,000 shares@ US$1.9013.2% of flowCommon StockSEC:0001437749-21-024196:0
Canonical exit: 20 Jan 2022 (T+90)
3,000 shares@ US$1.9113.3% of flowCommon StockSEC:0001437749-21-023910:0
Canonical exit: 17 Jan 2022 (T+90)
18 of 18 declarations
About Fraser Craig
Fraser Craig is President and CEO of Windtree Therapeutics INC (XNAS). He has filed 18 disclosures in total, and across the 18 sampled filings from 2021-10-19 to 2024-10-09, the transactions are acquisitions with a combined amount of EUR 37129, with no reported sales.
